BioThera Solutions
BioThera Solutions: “Canadian biotechnology company building a fully integrated extracellular vesicle (EV, exosome) platform, from research and intellectual property to manufacturing and partnering. It licenses its technology exclusively to Vesera, a skincare company, for cosmetic applications and produces the EV material Vesera uses, while its R&D team investigates further applications, including therapeutic ones.”
What are extracellular vesicles (EVs/exosomes)?
“Extracellular vesicles are nanoscale particles secreted by virtually every cell type. Each particle is a membrane-bound sphere built around a lipid bilayer, carrying a cargo of proteins, lipids, and nucleic acids that can influence gene expression and signalling in recipient cells.”
View in the company profileAre all EV/exosome products the same?
“No, and this is the most critical thing to understand about the EV space. There is no such thing as a generic exosome product.”
View in the company profileDo EVs from different sources have different biological properties?
“Yes, substantially so. The molecular payload of an EV is a direct reflection of the cell or organism that produced it.”
View in the company profileWhy are EVs gaining attention in dermatology and regenerative medicine?
“EVs represent a natural biological communication system, they are how cells transfer functional molecular information to one another. In dermatology, EVs show potential to support skin repair, modulate inflammation, promote regenerative signalling, and activate pathways involved in collagen synthesis and barrier function.”
View in the company profile